Bococizumab SPIRE-2 Cardiovascular Outcome Study Fully Enrolled

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/11/2026

1. ORCL
2. SPY
3. CHWY
4. NAVN
5. SPCX
6. USO
7. HUMA
8. cASY
9. CME
10. OXM

Go back to Bococizumab SPIRE-2 Cardiovascular Outcome Study Fully Enrolled
Pfizer Inc. (NYSE: PFE) Delayed: 26.36 +0.76 (2.97%)
Previous Close $25.60    52 Week High $37.39 
Open $25.79    52 Week Low $28.25 
Day High $26.48    P/E 15.98 
Day Low $25.79    EPS $1.65 
Volume 17,615,250